SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceutical informs about confirmation certificate

10 Apr 2025 Evaluate

Pursuant to Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018, Welcure Drugs & Pharmaceutical has submitted the confirmation certificate received from its Registrar and Transfer Agent - Skyline Financial Services for the quarter and Annual Year ended 31 March, 2025.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.28 0.00 (0.00%)
18-Jun-2026 16:00 View Price Chart
Peers
Company Name CMP
Redington 271.85
Amrapali Industries 42.64
Adani Enterprises 3013.10
Rashi Peripheral 730.80
PDS 344.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: